000 | 01965nam a2200385 a 4500 | ||
---|---|---|---|
001 | 0000141054 | ||
005 | 20171002061715.0 | ||
006 | m u | ||
007 | cr cn||||||||| | ||
008 | 110317s2011 dcuad sb 001 0 eng d | ||
010 | _z 2011012020 | ||
020 | _z9780821387603 | ||
020 | _z9780821387719 (e-book) | ||
035 | _a(CaPaEBR)ebr10506408 | ||
035 | _a(OCoLC)769188453 | ||
040 |
_aCaPaEBR _cCaPaEBR |
||
050 | 1 | 4 |
_aRA401.A1 _bR63 2011eb |
082 | 0 | 4 |
_a615.1 _222 |
100 | 1 | _aRoberts, Marc J. | |
245 | 1 | 0 |
_aPharmaceutical reform _h[electronic resource] : _ba guide to improving performance and equity / _cMarc J. Roberts and Michael R. Reich. |
260 |
_aWashington, D.C. : _bWorld Bank, _cc2011. |
||
300 |
_axx, 332 p. : _bill. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aIntroduction -- Using the flagship framework to reform pharmaceutical policy -- Introduction to the pharmaceutical sector -- Ethics and priority setting in pharmaceutical reform -- Diagnosing performance problems and developing a policy response -- Managing the politics of pharmaceutical policy reform -- Financing the pharmaceutical sector -- Paying for pharmaceuticals -- Organizing the public sector to improve pharmaceutical performance -- Improving pharmaceutical performance through regulation -- Using persuasion to influence pharmaceutical use -- Conclusions. | |
533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2011. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
650 | 0 | _aPharmaceutical policy. | |
650 | 0 | _aPharmaceutical industry. | |
650 | 0 | _aHealth care reform. | |
655 | 7 |
_aElectronic books. _2local |
|
700 | 1 |
_aReich, Michael, _d1950- |
|
710 | 2 | _aWorld Bank. | |
710 | 2 | _aebrary, Inc. | |
856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/daystar/Doc?id=10506408 _zAn electronic book accessible through the World Wide Web; click to view |
908 | _a170314 | ||
942 | 0 | 0 | _cEB |
999 |
_c130203 _d130203 |